Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKTX | IMRN | ERNA | ||
| Company | Akari Therapeutics ADR | Immuron Ltd ADR | Eterna Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5500 | 2.48 | 2.12 | ||
| High | 1.6500 | 2.48 | 2.12 | ||
| Low | 1.5500 | 2.36 | 2.10 | ||
| Last | 1.6500 | 2.41 | 2.10 | ||
| Change | +0.0150 | -0.09 | -0.06 | ||
| % Change | +0.92% | -3.50% | -2.78% | ||
| Volume | 6,307 | 1,900 | 810 | ||
| 20-Day Average Volume | 22,366 | 9,620 | 6,835 | ||
| Previous Close | 1.6350 | 2.50 | 2.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 1.3291 | 2.48 | 1.96 | ||
| 20-Day Raw Stochastic | 59.80% | 38.95% | 65.82% | ||
| 20-Day Relative Strength | 50.10% | 48.09% | 52.86% | ||
| Weighted Alpha | -56.91 | -40.91 | -22.56 | ||
| Today's Opinion | 72% Sell | 40% Buy | 48% Buy | ||
| Previous Opinion | 72% Sell | 48% Buy | 64% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +13.97% since 05/03/24 | -4.92% since 05/02/24 | +13.21% since 05/03/24 | ||
| Low | 1.1701 on 05/06/24 | 2.36 on 05/09/24 | 1.72 on 05/06/24 | ||
| High | 1.7500 on 05/09/24 | 2.62 on 05/07/24 | 2.30 on 05/08/24 | ||
| 1-Month | |||||
| %Chg | +19.23% since 04/10/24 | -12.34% since 04/09/24 | -7.08% since 04/10/24 | ||
| Low | 1.0775 on 04/17/24 | 2.15 on 04/16/24 | 1.58 on 04/26/24 | ||
| High | 1.8676 on 05/02/24 | 3.09 on 04/10/24 | 2.45 on 04/12/24 | ||
| 3-Month | |||||
| %Chg | -35.42% since 02/09/24 | +35.67% since 02/09/24 | +26.83% since 02/09/24 | ||
| Low | 1.0775 on 04/17/24 | 1.65 on 03/04/24 | 1.43 on 02/26/24 | ||
| High | 2.4400 on 03/04/24 | 5.96 on 03/07/24 | 2.57 on 03/12/24 | ||
| 6-Month | |||||
| %Chg | -54.14% since 11/10/23 | +63.07% since 11/09/23 | +77.97% since 11/10/23 | ||
| Low | 1.0775 on 04/17/24 | 1.53 on 11/10/23 | 0.84 on 12/01/23 | ||
| High | 3.5700 on 11/14/23 | 5.96 on 03/07/24 | 2.57 on 03/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,955 | 13,765 | 11,686 | ||
| Shares Outstanding, K | 7,924 | 5,700 | 5,410 | ||
| Annual Sales | 0 | 1,210,000 | 70,000 | ||
| Annual Net Income | -10,010,000 | -2,550,000 | -21,670,000 | ||
| Last Quarter Sales | 0 | N/A | 20,000 | ||
| Last Quarter Net Income | -5,680,000 | N/A | -6,150,000 | ||
| 60-Month Beta | 0.99 | 1.48 | 4.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/27/22 | N/A | -1.14 on 03/14/24 | ||
| Latest Earnings Date | 05/06/24 | 08/30/23 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||